Flavonifractor plautii Bacteremia With Generalized Peritonitis: A Case Report and Literature Review

Shogo Saito1, Shigeaki Baba2, Haruka Nikai2

  • 1Division of Central Clinical Laboratory, Iwate Medical University Hospital, Yahaba, JPN.

Cureus
|August 6, 2024
PubMed

Insights

Flavonifractor plautii bacteremia is rare in humans. This case highlights successful treatment with piperacillin/tazobactam in an immunocompromised patient with peritonitis.

Area of Science:

  • Microbiology
  • Clinical Medicine

Background:

  • Flavonifractor plautii is an anaerobic gut bacterium.
  • Human gut microbiota composition is crucial for health.

Observation:

  • A case of bacteremia caused by F. plautii in an 83-year-old male with hepatocellular carcinoma, gastric cancer, and cerebral infarction is presented.
  • The patient presented with acute generalized peritonitis and was mildly immunocompromised.

Findings:

  • F. plautii was identified in blood cultures prior to surgery.
  • The patient received piperacillin/tazobactam for 11 days and was discharged without recurrence.
  • Gram staining revealed variations in bacterial length, a characteristic of F. plautii.

Implications:

  • This case suggests piperacillin/tazobactam may be effective for F. plautii bacteremia.
  • Further research is needed to establish optimal antimicrobial therapy and understand resistance mechanisms for F. plautii.